The prevalence of the successful development of Alzheimer's vaccine will be halved
Release time: 2012-06-12 & nbsp & nbsp & nbsp Source:
According to the British "Daily Mail" website reported on June 8: Scholars from the Karolinska Research Institute and "Swedish Stake Sports BettingStake Sports BettingBrainstorm Network" recently developed a pioneering vaccine CAD106，Can reduce half of the cases of dementia。According to the World Health Organization Statistics，Alzheimer's disease is the fastest growing disease in the world today，In the UK，820,000 people are troubled by dementia，Half of which suffers from Alzheimer's disease。WHO estimate，In less than 10 years in the future，The number of dementia patients in the UK will increase to 1 million。
Alzheimer's disease is the most common dementia，It attacks human nerves、Brain cells and nerve conduction materials。According to statistics from the Association of Alzheimer's Association，People over 65 years old，One of the 14 people suffers from this disease。and the risk of diseases of Alzheimer's disease will increase with age，After 80 years old，1 person every 6 people get sick。
Now，A pioneering vaccine that can reduce half of the cases of dementia stake betting apphas been developed successfully。
stake online sports bettingThis injection vaccine developed by Swedish scientists is currently called CAD106，It helps patients to produce protective antibodies，Prevent patients in the patient's brain from generating，From this，It can effectively delay the impact of dementia on the human body。This is a very important step to find a way to cure this disease。
Researcher of this vaccine，Karolinska Institute (Karolinska Institute) and "Swedish Brain Power Network" scholars' scholars in the well -known academic journal "Lancet Neurology" (Lancet NEUROGY "(Lancet Neurology) magazine (Lancet NEUROGY) magazine (Lancet Neurology" (Lancet NEUROGY) magazine，Their research results can effectively help patients with mild to moderate elderly dementia，And，They hope that CAD106 can delay the occurrence of dementia for five years。
In a study that lasted more than three years for people 50-80 years old，Researchers My stake betting apphave not found that this drug has serious side effects。
The head of the British Alzheimer ’s Research UK Dr. Simon Ridley said，CAD106 long -term large -scale test will decide whether to help people recover memory and thinking，and reduce the number of starch in the brain。Researchers found that in patients using CAD106，74%of patients with rising antibody levels in the body，This means that the vaccine has successfully stimulated the human immune system。
In another article about this study，Thomas WISNIEWSKI at the New York Medical School wrote，"This immunotherapy can delay the occurrence of dementia for 5 years，So it will also reduce the disease rate by half。Developing the ultimate success immunotherapy will be a long road，and this new vaccine is a very promising step。”
Alzheimer's disease is the most common dementia，It attacks human nerves、Brain cells and nerve conduction materials。According to statistics from the Association of Alzheimer's Association，People over 65 years old，One of the 14 people suffers from this disease。and the risk of diseases of Alzheimer's disease will increase with age，After 80 years old，1 person every 6 people get sick。
Now，A pioneering vaccine that can reduce half of the cases of dementia stake betting apphas been developed successfully。
stake online sports bettingThis injection vaccine developed by Swedish scientists is currently called CAD106，It helps patients to produce protective antibodies，Prevent patients in the patient's brain from generating，From this，It can effectively delay the impact of dementia on the human body。This is a very important step to find a way to cure this disease。
Researcher of this vaccine，Karolinska Institute (Karolinska Institute) and "Swedish Brain Power Network" scholars' scholars in the well -known academic journal "Lancet Neurology" (Lancet NEUROGY "(Lancet Neurology) magazine (Lancet NEUROGY) magazine (Lancet Neurology" (Lancet NEUROGY) magazine，Their research results can effectively help patients with mild to moderate elderly dementia，And，They hope that CAD106 can delay the occurrence of dementia for five years。
In a study that lasted more than three years for people 50-80 years old，Researchers My stake betting apphave not found that this drug has serious side effects。
The head of the British Alzheimer ’s Research UK Dr. Simon Ridley said，CAD106 long -term large -scale test will decide whether to help people recover memory and thinking，and reduce the number of starch in the brain。Researchers found that in patients using CAD106，74%of patients with rising antibody levels in the body，This means that the vaccine has successfully stimulated the human immune system。
In another article about this study，Thomas WISNIEWSKI at the New York Medical School wrote，"This immunotherapy can delay the occurrence of dementia for 5 years，So it will also reduce the disease rate by half。Developing the ultimate success immunotherapy will be a long road，and this new vaccine is a very promising step。”
